BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 4287521)

  • 1. An improved method for the radioisotopic labeling of poliovirus and vaccinia virus. SAM-TR-66-29.
    Giron DJ
    Tech Rep SAM-TR; 1966 Apr; ():1-3. PubMed ID: 4287521
    [No Abstract]   [Full Text] [Related]  

  • 2. Early virus protein synthesis in vaccinia virus-infected cells.
    Esteban M; Metz DH
    J Gen Virol; 1973 May; 19(2):201-6. PubMed ID: 4268458
    [No Abstract]   [Full Text] [Related]  

  • 3. [Development of vaccinia virus in calf fetus kidney cells at optimal and supraoptimal temperatures. II. Kinetic study of viral DNA synthesis].
    Burkard G; Braunwald J; Guir J; Brendel A; Kirn A
    Ann Inst Pasteur (Paris); 1968 Dec; 115(6):1018-28. PubMed ID: 4890578
    [No Abstract]   [Full Text] [Related]  

  • 4. Argininosuccinate synthetase-lyase activity in vaccinia virus-infected HeLa and mouse L cells.
    Williamson JD; Cooke BC
    J Gen Virol; 1973 Nov; 21(2):349-57. PubMed ID: 4271656
    [No Abstract]   [Full Text] [Related]  

  • 5. Replication of vaccinia DNA in mouse L cells. II. In vitro DNA synthesis in cytoplasmic extracts.
    Esteban M; Holowczak JA
    Virology; 1977 May; 78(1):76-86. PubMed ID: 140514
    [No Abstract]   [Full Text] [Related]  

  • 6. Fluorinated pyrimidines. 38. The incorporation of 5-trifluoromethyl-2'-deoxyuridine into the deoxyribonucleic acid of vaccinia virus.
    Fujiwara Y; Heidelberger C
    Mol Pharmacol; 1970 May; 6(3):281-91. PubMed ID: 5443533
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of metabolic inhibitors in studies on the mode of replication of vaccinia virus.
    Salzman NP; Shatkin AJ; Sebring ED
    Ann N Y Acad Sci; 1965 Jul; 130(1):240-8. PubMed ID: 4221777
    [No Abstract]   [Full Text] [Related]  

  • 8. Glycoprotein synthesis in cells infected with vaccinia virus. I. Non-virion glycoproteins.
    Moss B; Rosenblum EN; Garon CF
    Virology; 1971 Nov; 46(2):221-32. PubMed ID: 4256994
    [No Abstract]   [Full Text] [Related]  

  • 9. Vaccinia mRNA synthesis under conditions which prevent uncoating.
    Woodson B
    Biochem Biophys Res Commun; 1967 Apr; 27(2):169-75. PubMed ID: 4226809
    [No Abstract]   [Full Text] [Related]  

  • 10. Purification and characterization of bluetongue virus.
    Verwoerd DW
    Virology; 1969 Jun; 38(2):203-12. PubMed ID: 4306588
    [No Abstract]   [Full Text] [Related]  

  • 11. THE SYNTHESIS OF A DNA-LIKE RNA IN THE CYTOPLASM OF HELA CELLS INFECTED WITH VACCINIA VIRUS.
    SALZMAN NP; SHATKIN AJ; SEBRING ED
    J Mol Biol; 1964 Mar; 8():405-16. PubMed ID: 14168694
    [No Abstract]   [Full Text] [Related]  

  • 12. NUCLEIC ACID METABOLISM IN MONOLAYERS OF HELA CELLS INFECTED WITH A DNA- AND A RNA-VIRUS.
    COCITO C
    Arch Gesamte Virusforsch; 1964; 14():201-14. PubMed ID: 14141580
    [No Abstract]   [Full Text] [Related]  

  • 13. Susceptibility of HeLa cells in S-phase to inhibition of DNA synthesis by poliovirus infection.
    Ackermann WW; Powers CD; Wahl D
    Proc Soc Exp Biol Med; 1966 Dec; 123(3):827-30. PubMed ID: 4289525
    [No Abstract]   [Full Text] [Related]  

  • 14. [Enzymatic aspects of the host cell-virus relation. I. Meaning of the presence of lactate dehydrogenase and of glutamic-oxaloacetic transaminase in cell cultures infected with cytopathogenic viruses of DNA and RNA type].
    Gaico N; Marx A; Sendrea M
    Arch Roum Pathol Exp Microbiol; 1967 Sep; 26(3):565-72. PubMed ID: 4298430
    [No Abstract]   [Full Text] [Related]  

  • 15. On the participation of nuclei in the synthesis of poliovirus ribonucleic acid.
    Zalmanzon ES; Lobareva LS
    Acta Virol; 1966 Jul; 10(4):301-9. PubMed ID: 4380507
    [No Abstract]   [Full Text] [Related]  

  • 16. DEMONSTRATION OF RAPIDLY LABELLED RNA FRACTIONS IN VIRUS-INFECTED HELA CELLS.
    LOH PC
    Proc Soc Exp Biol Med; 1964 Oct; 117():192-5. PubMed ID: 14219943
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of metabolic inhibitors on the production of vaccinia haemagglutinin.
    Aasen J; Haukenes G
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1972; 80(2):246-50. PubMed ID: 4260757
    [No Abstract]   [Full Text] [Related]  

  • 18. Control of thymidine kinase synthesis in IHD vaccinia virus-infected thymidine kinase-deficient LM cells.
    Zaslavsky V; Yakobson E
    J Virol; 1975 Jul; 16(1):210-3. PubMed ID: 124355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccinia as a model for membrane biogenesis.
    Dales S; Mosbach EH
    Virology; 1968 Aug; 35(4):564-83. PubMed ID: 5677800
    [No Abstract]   [Full Text] [Related]  

  • 20. PROPERTIES OF NUCLEIC ACIDS IN A PURIFIED VACCINIA VIRUS AND IN VACCINIA-INFECTED HELA CELLS.
    NISHIMURA C
    Jpn J Med Sci Biol; 1965 Apr; 18():121-6. PubMed ID: 14319488
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.